Information on the total number of voting rights and shares

Press release - regulated information Ghent, BELGIUM, Jan.31, 2024(GLOBE NEWSWIRE) --Biotalys NV(hereafter the“Company”or“Biotalys ”), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for crop protection, today announces that62,499 new shareswere issued on19 January 2024as a result of the exercise of subscription rights under the Company's long term incentive plan.In view hereof, and in accordance with article 15 of the...

Gent, 31/01/2024 (informazione.it - comunicati stampa - cibi e bevande)

Press release - regulated information

Ghent, BELGIUM, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Biotalys NV (hereafter the “Company” or “Biotalys ”), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for crop protection, today announces that 62,499 new shares were issued on 19 January 2024 as a result of the exercise of subscription rights under the Company's long term incentive plan.

In view hereof, and in accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major shareholdings (the “ Belgian Act ”), the outstanding share capital and outstanding voting securities of the Company can be summarised as follows:

Pursuant to the Belgian Act, a notification to the Company and the Belgian Financial Services and Markets Authority (FSMA) is required by all natural and legal persons in each case where the percentage of voting rights attached to the securities held by such persons in the Company reaches, exceeds or falls below the threshold of 5%, 10%, and every subsequent multiple of 5%, of the total number of voting rights in the Company.

For further information, please contact:  
Toon Musschoot, Head Investor Relations & Communication
T: +32 (0)9 274 54 00
E: IR@biotalys.com

About Biotalys

Biotalys is an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for the protection of crops and food and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and has been listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.

Attachments